Related references
Note: Only part of the references are listed.Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium
Andreas Machens et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Multiple Endocrine Neoplasia Type 2A Due to an Exon 8 (G533C) Mutation in a Large North American Kindred
M. Regina Castro et al.
THYROID (2013)
The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association
Laura Fugazzola et al.
THYROID RESEARCH (2013)
2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer
R. Elisei et al.
EUROPEAN THYROID JOURNAL (2012)
RET gene mutations and polymorphisms in medullary thyroid carcinomas in Indian patients
B. P. Sharma et al.
JOURNAL OF BIOSCIENCES (2011)
Molecular Analysis of the RET Proto-Oncogene Key Exons in Patients with Medullary Thyroid Carcinoma: A Comprehensive Study of the Iranian Population
Ehsan Alvandi et al.
THYROID (2011)
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes
Cristina Romei et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Sporadic hypercalcitoninemia: clinical and therapeutic consequences
C. Scheuba et al.
ENDOCRINE-RELATED CANCER (2009)
Mutational Spectrum of Multiple Endocrine Neoplasia Type 2 and Sporadic Medullary Thyroid Carcinoma in Taiwan
Chin-Feng Chang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2009)
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Richard T. Kloos et al.
THYROID (2009)
A new germline point mutation in Ret exon 8 (Cys515Ser) in a family with medullary thyroid carcinoma
Francesca Fazioli et al.
THYROID (2008)
Clinical and genetic experience in Turkish multiple endocrine neoplasia type 2 families
Murat Faik Erdogan et al.
ENDOCRINOLOGIST (2007)
RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotype
Giovanni Pinna et al.
THYROID (2007)
Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal
Hugo Joao Prazeres et al.
CLINICAL ENDOCRINOLOGY (2006)
RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A
YJ Chung et al.
THYROID (2004)
Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic
S Jindrichová et al.
JOURNAL OF ENDOCRINOLOGY (2004)
A novel germ-line point mutation in RET exon 8 (Gly533Cys) in a large kindred with familial medullary thyroid carcinoma
AMA Da Silva et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Familial medullary thyroid carcinoma with noncysteine RET mutations: Phenotype-genotype relationship in a large series of patients
P Niccoli-Sire et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Share Paper
